Welcome
Support Centre
07 August 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Writing about emotional experiences to reduce symptoms, improve quality of life and improve lung function in patients with asthma: a randomised controlled trial
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN82986307
Date ISRCTN assigned30/09/2004
Local reference number(s)N0051127195
Public titleWriting about emotional experiences to reduce symptoms, improve quality of life and improve lung function in patients with asthma: a randomised controlled trial
Scientific title
AcronymN/A
Disease/condition/study domainRespiratory: Asthma
Study hypothesis1. Can writing about stressful experiences decrease symptoms, improve quality of life and improve lung function in patients with asthma?
2. For how long are these improvements sustained?
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaAdult patients (18-45) registered with participating general practices with a diagnosis of asthma and requiring regular inhaled medication (British Thoracic Society [BTS] steps 2-4). The upper age limit has been chosen to exclude people whose respiratory problems may be due to chronic obstructive pulmonary disease (COPD).
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/05/2003
Anticipated end date30/06/2008
Status of trialOngoing
Target number of participantsWe aim to recruit 144 participants into the main study
InterventionsA pragmatic, randomised controlled trial of expressive writing for patients with asthma versus no writing.

Contact for public queries:
Alice Theadom
Email: a.theadom@bsms.ac.uk
Primary outcome measure(s)Lung function (forced expiratory volume in one second [FEV1], peak expiratory flow [PEF]) (primary outcome). Symptom scores, quality of life, medication use and health service use will be used as secondary outcome measures.
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingPilot phase funded by:
1. Brighton and Sussex University Hospitals NHS Trust (UK)
2. Asthma Research UK (UK)

RCT funded by:
Asthma UK (UK)
Sponsor nameRecord Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
Sponsor detailsThe Department of Health, Richmond House, 79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.dh.gov.uk/Home/fs/en
Contact nameProf Helen Smith
Contact detailsBrighton & Sussex Medical School
Falmer
Brighton
United Kingdom
BN1 9PH
Contact emailH.E.Smith@bsms.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN82986307
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central